Royalty Pharma· RPRX · NasdaqHeld by 198 US ETFsOpen stock report

ETFs That Hold Royalty Pharma (RPRX)

Name: ETFs That Hold Royalty Pharma (RPRX): Fund List & Weights
Creator: Tenet Investing
License: https://tenetinvesting.com/methodology

Like Royalty Pharma but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.

Lens

the cleanest, most concentrated way to own it

Embeds on the RPRX stock report“ETF Exposure” card · top 5 by weight

PBE

5.1%

RPRX weight

PTNT

4.7%

RPRX weight

IHE

4.7%

RPRX weight

ELCV

4.1%

RPRX weight

ADPV

3.7%

RPRX weight

Issuer

Include leveraged / inverse

Fund	Issuer	RPRX weight · shared scale	Expense	AUM
PBE Invesco Biotechnology & Genome ETF	Invesco	5.1%	0.59%	$431.9M	›
PTNT Corgi IP Licensing & Royalties ETF	Corgi Funds	4.7%	0.35%	$1.1M	›
IHE iShares U.S. Pharmaceuticals ETF	IShares	4.7%	0.37%	$1.5B	›
ELCV Eventide High Dividend ETF	Eventide	4.1%	0.49%	$291.0M	›
ADPV Adaptiv Select ETF	Adaptiv	3.7%	1.00%	$177.1M	›

The remaining 193 funds holding RPRX are available on a paid plan.Premium · $119/yr · 7-day trial · cancel anytimeUnlock every holder →

198 US-listed holders · fee and assets from the nightly fund profilePage 1 / 1

Comparing a few? Check their overlapCompare →Want the cheapest broad option? Screen all holdersScreener →

Reverse lookup across 1,438 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.

Common questions

How many ETFs hold Royalty Pharma (RPRX)?

Royalty Pharma (RPRX) is held by 198 US-listed ETFs, in each fund's latest reported holdings.

Which ETF holds the most Royalty Pharma?

Of the US-listed ETFs in our fund data, Invesco Biotechnology & Genome ETF (PBE) holds Royalty Pharma at the largest portfolio weight, in each fund's latest reported holdings.

What ETFs hold Royalty Pharma?

By portfolio weight, the US-listed ETFs that hold the most Royalty Pharma are PBE, PTNT, IHE, ELCV and ADPV, among others, in each fund's latest reported holdings.

Install Tenet on your phone

Data from Intrinio and Financial Modeling Prep.